We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Intellia Therapeutics
NTLA
$1.67B
| $9.28M | ﹤0.01% |
441,283
+144,568
| +49% | +$2.46M |
|
1527
Pathward Financial
CASH
$1.8B
| $9.26M | ﹤0.01% |
509,440
-36,010
| -7% | -$631K |
|
1528
Middleby
MIDD
$6.08B
| $9.23M | ﹤0.01% |
116,963
-18,057
| -13% | -$1.17M |
|
1529
Brady Corp
BRC
$4.57B
| $9.22M | ﹤0.01% |
196,982
-60,792
| -24% | -$2.8M |
|
|
BZUN
1530
Baozun
BZUN
$172M
| $9.22M | ﹤0.01% |
239,668
-46,110
| -16% | -$1.45M |
|
1531
Albany International
AIN
$1.78B
| $9.21M | ﹤0.01% |
156,829
-36,809
| -19% | -$1.99M |
|
1532
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
| $9.21M | ﹤0.01% |
96,000
| – | – |
|
1533
Valmont Industries
VMI
$9.53B
| $9.18M | ﹤0.01% |
80,777
-2,310
| -3% | -$256K |
|
1534
Ralph Lauren
RL
$23.6B
| $9.18M | ﹤0.01% |
126,522
+4,021
| +3% | +$296K |
|
1535
Aaon
AAON
$7.77B
| $9.16M | ﹤0.01% |
253,211
+10,104
| +4% | +$340K |
|
|
THS
1536
DELISTED
Treehouse Foods
THS
| $9.16M | ﹤0.01% |
209,135
+86,074
| +70% | +$4.2M |
|
1537
First Financial Bancorp
FFBC
$3.53B
| $9.15M | ﹤0.01% |
659,107
+250,938
| +61% | +$3.46M |
|
|
STAY
1538
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $9.14M | ﹤0.01% |
817,215
+60,728
| +8% | +$636K |
|
|
DENN
1539
DELISTED
Denny's
DENN
| $9.14M | ﹤0.01% |
905,305
+573,773
| +173% | +$5.89M |
|
1540
First Bancorp
FBP
$4.38B
| $9.14M | ﹤0.01% |
1,634,884
-110,050
| -6% | -$596K |
|
|
DRNA
1541
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $9.13M | ﹤0.01% |
359,362
-32,848
| -8% | -$708K |
|
1542
Mercury Insurance
MCY
$6.07B
| $9.13M | ﹤0.01% |
223,936
-89,737
| -29% | -$3.6M |
|
1543
Eagle Materials
EXP
$6.57B
| $9.11M | ﹤0.01% |
129,677
-161,772
| -56% | -$10.2M |
|
1544
Cloudflare
NET
$107B
| $9.1M | ﹤0.01% |
+253,191
| New | +$7.07M |
|
1545
Bath & Body Works
BBWI
$4.1B
| $9.07M | ﹤0.01% |
749,879
-80,593
| -10% | -$898K |
|
1546
Veracyte
VCYT
$3.8B
| $9.02M | ﹤0.01% |
348,204
-81,789
| -19% | -$2.04M |
|
1547
Skywest
SKYW
$4.34B
| $9.01M | ﹤0.01% |
276,236
+2,210
| +0.8% | +$65.4K |
|
1548
StoneX
SNEX
$7.94B
| $9.01M | ﹤0.01% |
829,319
+82,975
| +11% | +$720K |
|
1549
PRA Group
PRAA
$755M
| $9.01M | ﹤0.01% |
233,021
+23,495
| +11% | +$745K |
|
1550
Badger Meter
BMI
$4.03B
| $9M | ﹤0.01% |
143,058
+13,884
| +11% | +$824K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.